Epilepsy surgery for pharmacoresistant temporal lobe epilepsy: A decision analysis

JAMA

Volumn 300, Issue 21, 2008, Pages 2497-2505

  Choi, Hyunmi ^a,g   Sell, Randall L ^c   Lenert, Leslie ^d   Muennig, Peter ^b   Goodman, Robert R ^a   Gilliam, Frank G ^a,f   Wong, John B ^e  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Columbia University Mailman School of Public Health ^*  (United States)

^c DREXEL UNIVERSITY   (United States)

^d CDC   (United States)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

^g NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DECISION MAKING; GAMMA KNIFE RADIOSURGERY; HUMAN; MORTALITY; NERVE STIMULATION; PRIORITY JOURNAL; QUALITY OF LIFE; SENSITIVITY ANALYSIS; SURVIVAL; TEMPORAL LOBE EPILEPSY; VAGUS NERVE;

EID: 57349144887     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2008.771     Document Type: Article

References (67)

1. Engel J Jr, Wiebe S, French J, et al. Practice parameter: temporal lobe and localized neocortical resections for epilepsy. Neurology. 2003;60(4):538-547.
2. Engel J Jr. Etiology as a risk factor for medically refractory epilepsy: a case for early surgical intervention. Neurology. 1998;51(5):1243-1244.
3. Wiebe S. Epidemiology of temporal lobe epilepsy. Can J Neurol Sci. 2000;27(suppl 1):S6-S10.
4. Mohanraj R, Brodie MJ. Diagnosing refractory epilepsy: response to sequential treatment schedules. Eur J Neurol. 2006;13(3):277-282.
5. Stephen LJ, Kelly K, Mohanraj R, Brodie MJ. Pharmacological outcomes in older people with newly diagnosed epilepsy. Epilepsy Behav. 2006;8(2):434-437.
6. Engel J Jr. Update on surgical treatment of the epilepsies. Neurology. 1993;43(8):1612-1617.
7. Lhatoo SD, Solomon JK, McEvoy AW, et al. A prospective study of the requirement for and the provision of epilepsy surgery in the United Kingdom. Epilepsia. 2003;44(5):673-676.
8. Lee BI. Current status and future direction of epilepsy surgery in Asia. Neurology Asia. 2004;9:47-48.
9. Wiebe S, Blume WT, Girvin JP, Eliasziw M. A randomized, controlled trial of surgery for temporallobe epilepsy. N Engl J Med. 2001;345(5):311-318.
10. Spencer SS, Berg AT, Vickrey BG, et al. Initial outcomes in the Multicenter Study of Epilepsy Surgery. Neurology. 2003;61(12):1680-1685.
11. Benbadis SR, Heriaud L, Tatum WO, Vale FL. Epilepsy surgery, delays and referral patterns-are all your epilepsy patients controlled? Seizure. 2003;12(3):167-170.
12. Engel J Jr. Mesial temporal lobe epilepsy: what have we learned? Neuroscientist. 2001;7(4):340-352.
13. Semah F, Picot MC, Adam C, et al. Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology. 1998;51(5):1256-1262.
14. Sperling MR. The consequences of uncontrolled epilepsy. CNS Spectr. 2004;9(2):98-101, 106-109.
15. Ryvlin P, Kahane P. Does epilepsy surgery lower the mortality of drug-resistant epilepsy? Epilepsy Res. 2003;56(2-3):105-120.
16. Salanova V, Markand O, Worth R. Temporal lobe epilepsy surgery. Epilepsia. 2002;43(2):170-174.
17. Sperling MR, Feldman H, Kinman J, et al. Seizure control and mortality in epilepsy. Ann Neurol. 1999;46(1):45-50.
18. Wiebe S, Jette N. Randomized trials and collaborative research in epilepsy surgery: future directions. Can J Neurol Sci. 2006;33(4):365-371.
19. Engel J Jr. The timing of surgical intervention for mesial temporal lobe epilepsy. Arch Neurol. 1999;56(11):1338-1341.
20. Burneo JG, Black L, Martin R, et al. Race/ethnicity, sex, and socioeconomic status as predictors of outcome after surgery for temporal lobe epilepsy. Arch Neurol. 2006;63(8):1106-1110.
21. Schwartz TH, Jeha L, Tanner A, et al. Late seizures in patients initially seizure free after epilepsy surgery. Epilepsia. 2006;47(3):567-573.
22. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188.
23. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21 (11):1539-1558.
24. Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decis Making. 1993;13(4):322-338.
25. Engel J Jr, Van Ness P, Rasmussen TB, Ojemann LM. Outcome with respect to epileptic seizures. In: Engel J Jr, ed. Surgical Treatment of the Epilepsies. 2nd ed. New York, NY: Raven Press; 1993:609-621.
26. Arias E. United States life tables, 2003. Natl Vital Stat Rep. 2006;54(14):1-40.
27. Kelley K, Theodore WH. Prognosis 30 years after temporal lobectomy. Neurology. 2005;64(11):1974-1976.
28. Foldvary N, Nashold B, Mascha E, et al. Seizure outcome after temporal lobectomy for temporal lobe epilepsy. Neurology. 2000;54(3):630-634.
29. Di Gennaro G, Quarato PP, Sebastiano F, et al. Postoperative EEG and seizure outcome in temporal lobe epilepsy surgery. Clin Neurophysiol. 2004;115(5):1212-1219.
30. Markand ON, Salanova V, Whelihan E, et al. Health-related quality of life outcome in medically refractory epilepsy treated with anterior temporal lobectomy. Epilepsia. 2000;41(6):749-759.
31. Uijl SG, Leijten FS, Arends JB, et al. Prognosis after temporal lobe epilepsy surgery. Epilepsia. 2008;49(8):1317-1323.
32. Kelemen A, Barsi P, Eross L, et al. Long-term outcome after temporal lobe surgery-prediction of late worsening of seizure control. Seizure. 2006;15(1):49-55.
33. Salanova V, Markand O, Worth R, et al. Longitudinal follow-up in 145 patients with medically refractory temporal lobe epilepsy treated surgically between 1984 and 1995. Epilepsia. 1999;40(10):1417-1423.
34. Burneo JG, Villanueva V, Knowlton RC, et al. Kaplan-Meier analysis on seizure outcome after epilepsy surgery: do gender and race influence it? Seizure. 2008;17(4):314-319.
35. Jeong SW, Lee SK, Hong KS, et al. Prognostic factors for the surgery for mesial temporal lobe epilepsy. Epilepsia. 2005;46(8):1273-1279.
36. Jeha LE, Najm IM, Bingaman WE, et al. Predictors of outcome after temporal lobectomy for the treatment of intractable epilepsy. Neurology. 2006;66(12):1938-1940.
37. McIntosh AM, Kalnins RM, Mitchell LA, et al. Temporal lobectomy. Brain. 2004;127(pt 9):2018-2030.
38. Choi H, Heiman G, Pandis D, et al. Seizure remission and relapse in adults with intractable epilepsy. Epilepsia. 2008;49(8):1440-1445.
39. Annegers JF, Coan SP, Hauser WA, et al. Epilepsy, vagal nerve stimulation by the NCP system, mortality, and sudden, unexpected, unexplained death. Epilepsia. 1998;39(2):206-212.
40. Nilsson L, Ahlbom A, Farahmand BY, Tomson T. Mortality in a population-based cohort of epilepsy surgery patients. Epilepsia. 2003;44(4):575-581.
41. Nashef L, Fish DR, Sander JW, Shorvon SD. Incidence of sudden unexpected death in an adult outpatient cohort with epilepsy at a tertiary referral centre. J Neurol Neurosurg Psychiatry. 1995;58(4):462-464.
42. Torrance GW. Utility approach to measuring health-related quality of life. J Chronic Dis. 1987;40(6):593-603.
43. Muennig P. Designing and Conducting Cost-Effectiveness Analyses in Medicine and Health Care. San Francisco, CA: Jossey-Bass; 2002.
44. Pasta DJ, Taylor JL, Henning JM. Probabilistic sensitivity analysis incorporating the bootstrap. Med Decis Making. 1999;19(3):353-363.
45. Doubilet P, Begg CB, Weinstein MC, et al. Probabilistic sensitivity analysis using Monte Carlo simulation. Med Decis Making. 1985;5(2):157-177.
46. Penfield W, Flanigin M. The surgical therapy of temporal lobe seizures. Arch Neurol Psychiatry. 1950;64:491-500.
47. Bailey P, Gibbs FA. The surgical treatment of psychomotor epilepsy. JAMA. 1951;145:365-370.
48. Gilliam F, Kuzniecky R, Meador K, et al. Patient-oriented outcome assessment after temporal lobectomy for refractory epilepsy. Neurology. 1999;53(4):687-694.
49. Wright JC, Weinstein MC. Gains in life expectancy from medical interventions. N Engl J Med. 1998;339(6):380-386.
50. Tsevat J, Weinstein MC, Williams LW, et al. Expected gains in life expectancy from various coronary heart disease risk factor modifications. Circulation. 1991;83(4):1194-1201.
51. Wong JB, Sonnenberg FA, Salem DN, Pauker SG. Myocardial revascularization for chronic stable angina. Ann Intern Med. 1990;113(11):852-871.
52. Goldman L, Sia ST, Cook EF, et al. Costs and effectiveness of routine therapy with long-term betaadrenergic antagonists after acute myocardial infarction. N Engl J Med. 1988;319(3):152-157.
53. Hakimi AS, Spanaki MV, Schuh LA, et al. A survey of neurologists' views on epilepsy surgery and medically refractory epilepsy. Epilepsy Behav. 2008;13(1):96-101.
54. Elstein AS, Schwartz A. Clinical problem solving and diagnostic decision making [published correction appears in BMJ. 2006;333(7575):944]. BMJ. 2002;324(7339):729-732.
55. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. 2000;342(5):314-319.
56. Hitiris N, Mohanraj R, Norrie J, Brodie MJ. Mortality in epilepsy. Epilepsy Behav. 2007;10(3):363-376.
57. Langan Y, Nashef L, Sander JW. Sudden unexpected death in epilepsy. J Neurol Neurosurg Psychiatry. 2000;68(2):211-213.
58. Dasheiff RM. Sudden unexpected death in epilepsy: a series from an epilepsy surgery program and speculation on the relationship to sudden cardiac death. J Clin Neurophysiol. 1991;8(2):216-222.
59. Hennessy MJ, Langan Y, Elwes RD, et al. A study of mortality after temporal lobe epilepsy surgery. Neurology. 1999;53(6):1276-1283.
60. Spencer SS, Berg AT, Vickrey BG, et al. Predicting long-term seizure outcome after resective epilepsy surgery. Neurology. 2005;65(6):912-918.
61. Janszky J, Janszky I, Schulz R, et al. Temporal lobe epilepsy with hippocampal sclerosis. Brain. 2005;128(pt 2):395-404.
62. Langan Y, Nashef L, Sander JW. Case-control study of SUDEP. Neurology. 2005;64(7):1131-1133.
63. Spencer SS. Gamma knife radiosurgery for refractory medial temporal lobe epilepsy: too little, too late? Neurology. 2008;70(19):1654-1655.
64. The Vagus Nerve Stimulation Study Group. A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. Neurology. 1995;45(2):224-230.
65. Engel JJ, Cascino GD, Shields WD. Surgically remediable syndromes. In: Engel JJ, Pedley TA, eds. Epilepsy: A Comprehensive Textbook. Vol II. Philadelphia, PA: Lippincott Williams & Wilkins; 2008.
66. Gumnit RJ, Walczak TS. Guidelines for essential services, personnel, and facilities in specialized epilepsy centers in the United States. Epilepsia. 2001;42(6):804-814.
67. Duchowny MSHA, Sperling MR, Williamson PD. Indications and criteria for surgical intervention. In: Engel J Jr, Pedley TA, eds. Epilepsy: A Comprehensive Textbook. Vol 2. Philadelphia, PA: Lippincott Williams & Wilkins; 2008:1751-1759.